Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro.
Marcin KuneckiTomasz OleksyJan MartynówMichalina ZygmuntMarek DejaTomasz KargulJolanta BiernatPiotr PodolecKrzysztof S GołbaWojciech PłazakPublished in: BMC pharmacology & toxicology (2023)
Remifentanil, but not sufentanil, induces a cardioprotective effect on human right atria muscle in in vitro conditions, manifested as the increased amplitude of their contraction during reperfusion after 60 min of ischemia.
Keyphrases
- endothelial cells
- skeletal muscle
- induced pluripotent stem cells
- pluripotent stem cells
- heart failure
- cerebral ischemia
- acute myocardial infarction
- atrial fibrillation
- resting state
- left ventricular
- acute coronary syndrome
- ischemia reperfusion injury
- subarachnoid hemorrhage
- oxidative stress
- functional connectivity